Thrivent Financial for Lutherans Lowers Stake in Itron, Inc. $ITRI

Thrivent Financial for Lutherans lessened its stake in shares of Itron, Inc. (NASDAQ:ITRI) by 8.3% in the 4th quarter, Holdings Channel reports. The firm owned 71,079 shares of the scientific and technical instruments company’s stock after selling 6,409 shares during the period. Thrivent Financial for Lutherans’ holdings in Itron were worth $6,654,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Employees Retirement System of Texas acquired a new position in shares of Itron during the 3rd quarter worth about $32,000. Private Trust Co. NA raised its position in shares of Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after purchasing an additional 145 shares during the last quarter. Optiver Holding B.V. acquired a new position in shares of Itron during the 3rd quarter worth about $36,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Itron by 343.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after purchasing an additional 268 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd acquired a new position in shares of Itron during the 3rd quarter worth about $44,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Buying and Selling

In other news, SVP John F. Marcolini sold 1,074 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $107,582.58. Following the completion of the sale, the senior vice president owned 25,838 shares of the company’s stock, valued at $2,588,192.46. This represents a 3.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Laurie Ann Pulatie-Hahn sold 729 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $73,023.93. Following the completion of the sale, the senior vice president directly owned 32,950 shares of the company’s stock, valued at approximately $3,300,601.50. This trade represents a 2.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 10,331 shares of company stock worth $1,016,328 in the last 90 days. Corporate insiders own 1.77% of the company’s stock.

Itron Stock Up 4.3%

ITRI stock opened at $81.35 on Thursday. The company has a market cap of $3.61 billion, a price-to-earnings ratio of 12.97, a PEG ratio of 0.68 and a beta of 1.35. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. Itron, Inc. has a 12 month low of $77.77 and a 12 month high of $142.00. The firm has a 50-day moving average of $88.85 and a two-hundred day moving average of $94.73.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to the consensus estimate of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s quarterly revenue was down 3.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, analysts forecast that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ITRI has been the subject of several research analyst reports. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Guggenheim set a $155.00 price target on shares of Itron in a research report on Friday, February 13th. Roth Mkm restated a “buy” rating and set a $136.00 price target on shares of Itron in a research report on Wednesday, April 29th. JPMorgan Chase & Co. reduced their price target on shares of Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research report on Thursday, April 16th. Finally, Oppenheimer upped their price target on shares of Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday, April 16th. Eight research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $131.22.

Itron Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.